John R. Pollard

15.9k total citations
90 papers, 4.7k citations indexed

About

John R. Pollard is a scholar working on Molecular Biology, Oncology and Psychiatry and Mental health. According to data from OpenAlex, John R. Pollard has authored 90 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 25 papers in Oncology and 23 papers in Psychiatry and Mental health. Recurrent topics in John R. Pollard's work include DNA Repair Mechanisms (22 papers), Epilepsy research and treatment (22 papers) and Cancer-related Molecular Pathways (14 papers). John R. Pollard is often cited by papers focused on DNA Repair Mechanisms (22 papers), Epilepsy research and treatment (22 papers) and Cancer-related Molecular Pathways (14 papers). John R. Pollard collaborates with scholars based in United States, United Kingdom and Germany. John R. Pollard's co-authors include Peter Charlton, Philip M. Reaper, Julian M.C. Golec, Michael Mortimore, Jean‐Damien Charrier, Somhairle MacCormick, Jacqueline A. French, W. Gillies McKenna, Matthew R. Griffiths and Joanna Long and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Blood.

In The Last Decade

John R. Pollard

90 papers receiving 4.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John R. Pollard United States 37 2.8k 1.7k 694 539 468 90 4.7k
Athanassios P. Kyritsis United States 48 3.2k 1.1× 2.0k 1.2× 237 0.3× 179 0.3× 1.1k 2.3× 173 7.9k
Philip J. Tofilon United States 49 4.3k 1.5× 2.0k 1.2× 314 0.5× 131 0.2× 304 0.6× 166 7.7k
Yasuo Uchida Japan 34 1.5k 0.5× 2.3k 1.4× 267 0.4× 1.0k 1.9× 161 0.3× 112 4.7k
Stephen F. Madden Ireland 47 4.8k 1.7× 2.2k 1.3× 234 0.3× 336 0.6× 244 0.5× 164 8.1k
G S Tint United States 32 2.6k 0.9× 936 0.5× 132 0.2× 240 0.4× 219 0.5× 100 5.4k
Epie Boven Netherlands 45 3.0k 1.0× 3.3k 1.9× 175 0.3× 317 0.6× 235 0.5× 190 7.5k
Jun Wei China 31 1.8k 0.6× 501 0.3× 185 0.3× 207 0.4× 268 0.6× 169 3.6k
Eddy Pasquier France 32 1.9k 0.7× 1.4k 0.8× 289 0.4× 93 0.2× 125 0.3× 69 4.0k
Keith D. Wilner United States 45 3.2k 1.1× 6.2k 3.6× 571 0.8× 276 0.5× 838 1.8× 163 11.4k
Kimmo J. Hatanpaa United States 42 3.7k 1.3× 797 0.5× 289 0.4× 81 0.2× 485 1.0× 123 7.7k

Countries citing papers authored by John R. Pollard

Since Specialization
Citations

This map shows the geographic impact of John R. Pollard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John R. Pollard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John R. Pollard more than expected).

Fields of papers citing papers by John R. Pollard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John R. Pollard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John R. Pollard. The network helps show where John R. Pollard may publish in the future.

Co-authorship network of co-authors of John R. Pollard

This figure shows the co-authorship network connecting the top 25 collaborators of John R. Pollard. A scholar is included among the top collaborators of John R. Pollard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John R. Pollard. John R. Pollard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Haanpää, Maria K., John R. Pollard, Monica Traverso, et al.. (2024). Expanding the phenotype of UPF3B‐related disorder: Case reports and literature review. American Journal of Medical Genetics Part A. 194(6). e63534–e63534. 3 indexed citations
2.
Valenza, Alice, et al.. (2023). A Drosophila model targets Eiger/TNFα to alleviate obesity-related insulin resistance and macrophage infiltration. Disease Models & Mechanisms. 16(11). 5 indexed citations
3.
Biswas, Dipsikha, Leonard A. Daly, Christopher R. Browning, et al.. (2022). Mechanism of glycogen synthase inactivation and interaction with glycogenin. Nature Communications. 13(1). 3372–3372. 27 indexed citations
4.
Blanco, Jorge C. G., et al.. (2020). Classical Drug Digitoxin Inhibits Influenza Cytokine Storm, With Implications for Covid-19 Therapy. In Vivo. 34(6). 3723–3730. 37 indexed citations
5.
French, Jacqueline A., Robert Wechsler, Michael Gelfand, et al.. (2019). Inhaled alprazolam rapidly suppresses epileptic activity in photosensitive participants. Epilepsia. 60(8). 1602–1609. 35 indexed citations
6.
Pollard, John R., Ali R. Rajabi‐Siahboomi, Raj Badhan, Afzal R. Mohammed, & Yvonne Perrie. (2019). High-throughput screening of excipients with a biological effect: a kinetic study on the effects of surfactants on efflux-mediated transport. Journal of Pharmacy and Pharmacology. 71(6). 889–897. 18 indexed citations
7.
Halford, Jonathan J., Michael R. Sperling, Dileep Nair, et al.. (2017). Detection of generalized tonic–clonic seizures using surface electromyographic monitoring. Epilepsia. 58(11). 1861–1869. 80 indexed citations
8.
French, Jacqueline A., Daniel Friedman, Robert Wechsler, et al.. (2017). Inhaled Alprazolam, a Potential Rescue Medication, Works Rapidly in Patients with Photosensitive Epilepsy (P6.236). Neurology. 88(16_supplement). 3 indexed citations
9.
10.
Williamson, Chris T., Rowan Miller, Helen N. Pemberton, et al.. (2016). ATR inhibitors as a synthetic lethal therapy for tumours deficient in ARID1A. Nature Communications. 7(1). 13837–13837. 270 indexed citations
11.
Sanjiv, Kumar, Anna Hagenkort, José Manuel Calderón‐Montaño, et al.. (2015). Cancer-Specific Synthetic Lethality between ATR and CHK1 Kinase Activities. Cell Reports. 14(2). 298–309. 112 indexed citations
12.
Chen, Tao, et al.. (2014). Development of pharmacodynamic biomarkers for ATR inhibitors. Molecular Oncology. 9(2). 463–472. 15 indexed citations
13.
Swan, M.K., Adam Tanner, Philip M. Reaper, et al.. (2014). Structure of human Bloom's syndrome helicase in complex with ADP and duplex DNA. Acta Crystallographica Section D Biological Crystallography. 70(5). 1465–1475. 58 indexed citations
14.
Brown, Mesha‐Gay, Danielle A. Becker, John R. Pollard, & Christopher T. Anderson. (2013). The Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder in Patients with Epilepsy. Current Neurology and Neuroscience Reports. 13(6). 351–351. 2 indexed citations
15.
Roychowdhury, Sanjoy, Dian Chiang, Palash Mandal, et al.. (2012). Inhibition of Apoptosis Protects Mice from Ethanol‐Mediated Acceleration of Early Markers of CC l 4 ‐Induced Fibrosis but not Steatosis or Inflammation. Alcoholism Clinical and Experimental Research. 36(7). 1139–1147. 64 indexed citations
16.
Prevo, Remko, Emmanouil Fokas, Philip M. Reaper, et al.. (2012). The novel ATR inhibitor VE-821 increases sensitivity of pancreatic cancer cells to radiation and chemotherapy. Cancer Biology & Therapy. 13(11). 1072–1081. 191 indexed citations
17.
Mani, Ram, John R. Pollard, & Marc A. Dichter. (2011). Human clinical trails in antiepileptogenesis. Neuroscience Letters. 497(3). 251–256. 40 indexed citations
18.
Pollard, John R., et al.. (2011). Rescue Therapies for Seizures. Current Neurology and Neuroscience Reports. 11(4). 418–422. 13 indexed citations
19.
Liebeskind, David S., John R. Pollard, Eric D. Schwartz, et al.. (2002). Vertebrobasilar Thrombolysis with Intravenous Tirofiban: Case Report. Journal of Thrombosis and Thrombolysis. 13(2). 81–84. 5 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Athanassios P. Kyritsis Breakdown of academic impact, for papers by Philip J. Tofilon Breakdown of academic impact, for papers by Yasuo Uchida Breakdown of academic impact, for papers by Stephen F. Madden Breakdown of academic impact, for papers by G S Tint Breakdown of academic impact, for papers by Epie Boven Breakdown of academic impact, for papers by Jun Wei Breakdown of academic impact, for papers by Eddy Pasquier Breakdown of academic impact, for papers by Keith D. Wilner Breakdown of academic impact, for papers by Kimmo J. Hatanpaa
Rankless by CCL
2026